scispace - formally typeset
Open AccessJournal ArticleDOI

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.

Reads0
Chats0
TLDR
In this article, the authors describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.
About
This article is published in The Lancet.The article was published on 2021-01-16 and is currently open access. It has received 2933 citations till now. The article focuses on the topics: Pulmonary diffusion & Severity of illness.

read more

Citations
More filters
Journal ArticleDOI

Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages

TL;DR: SARS-CoV-2 infection leaves an inflammatory imprint in the monocyte/macrophage compartment that drives aberrant macrophage effector functions and eicosanoid metabolism, resulting in long-term immune aberrations in patients recovering from mild COVID-19.
Journal ArticleDOI

Long-COVID Headache.

TL;DR: The so-called long COVID-19 is a set of symptoms that accompanies the patient even for months after discharge from the hospital as discussed by the authors, and the symptoms include easy muscle fatigue, moderate breathlessness, persistent headache, the feeling of a foggy head and the development of psychiatric disorders.
Journal ArticleDOI

Long COVID-19 and Postural Orthostatic Tachycardia Syndrome- Is Dysautonomia to Be Blamed?

TL;DR: It is important to educate healthcare professionals to recognise complications and conditions arising from COVID-19, such as POTS, to allow prompt diagnosis and access to early treatment, and to elucidate the underlying mechanisms of dysautonomia to enable the development of targeted therapies.
Journal ArticleDOI

Brain MRI and neuropsychological findings at long-term follow-up after COVID-19 hospitalisation: an observational cohort study.

TL;DR: In this paper, the authors report findings on brain MRI and neurocognitive function, as well as persisting fatigue at long-term follow-up after COVID-19 hospitalisation in patients identified as high risk for affection of the central nervous system.
References
More filters
Journal ArticleDOI

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

TL;DR: A 5-level version of the EQ-5D has been developed by the EuroQol Group and further testing is required to determine whether the new version improves sensitivity and reduces ceiling effects.
Journal ArticleDOI

Dexamethasone in Hospitalized Patients with Covid-19

TL;DR: In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support.
Related Papers (5)
Trending Questions (1)
What is the implications of reshoring after covid?

The given text does not provide any information about the implications of reshoring after COVID-19.